Exploring the Interplay of Diabetes, Deaf Patient Reported Outcomes, and Cancer Screening in Deaf and Hard of Hearing Women
Emmanuel Perrodin-Njoku,Sowmya Rao,Regina Wang,Christopher Moreland,Poorna Kushalnagar
DOI: https://doi.org/10.2147/ijwh.s461490
2024-07-13
International Journal of Women s Health
Abstract:Emmanuel Perrodin-Njoku, 1 Sowmya R Rao, 2 Regina M Wang, 3 Christopher J Moreland, 4 Poorna Kushalnagar 1 1 Center for Deaf Health Equity, Gallaudet University, Washington, DC, USA; 2 Department of Global Health, Boston University School of Public Health, Boston, MA, USA; 3 Family Medicine and Public Health, University of California San Diego, San Diego, CA, USA; 4 Dell Medical School, University of Texas at Austin, Austin, TX, USA Correspondence: Poorna Kushalnagar, Gallaudet University, 800 Florida Avenue NE, Hall Memorial Building, Washington, DC, 20002, USA, Email Purpose: Some deaf and hard-of-hearing (DHH) individuals face health information barriers, increasing their risk of diabetes mellitus (DM) and subsequent cancer development. This study examines if health-related quality of life (HRQoL) and deaf patient-reported outcomes (DHH-QoL) mediate the relationship between DM diagnosis and cancer screening adherence among DHH individuals. Patients and Methods: In a cross-sectional study, US DHH adults assigned female at birth answered questions on cervical and breast cancer screenings from the ASL-English bilingual Health Information National Trends Survey (HINTS-ASL) and the PROMIS (Patient Reported Outcome Measurement Information System) Deaf Profile measure's Communication Health and Global Health domains. Odds ratios (OR) and 95% confidence intervals (CI) were obtained from multivariable logistic and linear regression models, examining the association between DM, DHH-QoL, and cancer screening adherence, adjusting for other covariates and HRQoL. A Baron and Kenny causal mediation analysis was used. A two-sided p < 0.05 indicated significance. Results: Most respondents were White (66.4%), heterosexual (66.2%), did not have DM (83.9%), had health insurance (95.5%), and adhered to pap smears (75.7%) and mammograms (76.9%). The average (standard deviation) DHH-QoL score was 50.9 (8.6). Those with DM had lower HRQoL scores (46.2 (9.5) vs 50.2 (8.8); p < 0.0001) than those without. Non-significant multivariable models indicate that those with DM were more adherent to pap testing (OR: 1.48; 95% CI: 0.72, 3.03; p = 0.285) and mammograms (2.18; 95% CI: 0.81, 5.88; p = 0.122), with DHH-QoL scores slightly increasing them to 1.53 (0.74, 3.16; p = 0.250) for pap testing and 2.55 (0.91, 7.13; p = 0.076) for mammograms. DHH-QoL was significantly associated with mammograms (p = 0.027), with 6% increased adherence per unit increase in the score. Overall, HRQoL and DHH-QoL were not significant mediators. Conclusion: While HRQoL/DHH-QoL in DHH individuals with DM does not mediate cancer screening adherence, higher DHH-QoL scores are associated with it. DHH-focused health literacy and communication training can improve cancer-related outcomes. Keywords: deaf, cancer screening, sign language, hearing loss, diabetes In the United States, diabetes mellitus (DM) is a significant public health concern, affecting 11.3% of the US population (37.3 million people), including both diagnosed and undiagnosed individuals. 1 Individuals with DM are at increased risk for comorbidities, leading to higher health care costs, lower quality of life, and increased mortality risk. Rates of DM are rising concurrently with rates of some cancers, supporting the long-standing hypothesis about a direct relationship between DM and cancer. 2 Several studies suggest that DM in particular, uncontrolled DM, may be causally associated with colorectal cancer, and potentially with other cancer types. 3–7 Also, several studies have quantified DM control as a predictor of cancer screening rates. Specifically, patients with high hemoglobin A1C measurements were less likely to have been screened for colorectal cancer, and women with DM are less likely to have received guideline-concordant breast or cervical cancer screenings. 8–12 Since people with uncontrolled DM are less likely to undergo recommended cancer screenings, increasing cancer screening rates should be a priority in caring for patients with DM. Even though the association between DM and cancer screening is not consistent after adjusting for factors known to be associated with diabetes and healthcare access, it is important for individuals with DM to adhere to recommended cancer screenings. 3,13,14 Furthermore, people with DM may face other barriers to managing their health, including health literacy, beliefs, financial resources, social support, culture, and language. 15,16 For American Sign Language-using (ASL) deaf and hard-of-hearing (DHH) community members who are diagnosed with diabetes, access to incidental information plays a significant role in sha -Abstract Truncated-
obstetrics & gynecology